AHR jumps as REIT expands revolver to $800M and extends maturity to 2030

AHRAHR

American Healthcare REIT (AHR) is moving higher as investors focus on its recently amended unsecured credit facility that expanded available revolving capacity to $800 million and extended revolving maturities to April 2030 (with extension options to 2031). The April 1, 2026 amendment also left the $550 million term loan maturity at January 19, 2027, signaling improved liquidity flexibility.

1. What’s driving the move

American Healthcare REIT shares are trading higher as the market digests the company’s recently updated financing package that increases balance-sheet flexibility. In its April 1, 2026 Form 8-K, AHR disclosed a second amendment to its 2024 credit agreement that reshaped the company’s unsecured revolver and term-loan structure, a change that can support near-term capital needs and reduce liquidity anxiety for REIT investors. (sec.gov)

2. The key details investors are reacting to

Under the amended agreement, AHR’s revolving loans now mature on April 1, 2030, with two extension options that could push maturity to October 1, 2030 and then April 1, 2031 if conditions are met and fees are paid. The available revolving loan principal amount increased to $800 million, while the term loans remain $550 million with a stated maturity of January 19, 2027. (sec.gov)

3. Why it matters for a healthcare REIT

For a REIT with ongoing funding needs—tenant improvements, redevelopment, selective acquisitions, and general corporate liquidity—more revolver capacity and a longer-dated maturity profile can lower perceived financing risk, particularly when interest-rate expectations and credit spreads are volatile. The filing also notes the facility’s SOFR-based pricing mechanics and standard REIT-style leverage and coverage covenants, which investors typically evaluate as a constraint (or enabler) for growth. (sec.gov)